Coral Laboratories
Coral Laboratories Share Price Chart
Coral Laboratories last traded at ₹560.90 (2026-10-13). Over the past month the stock moved -0.1%, three months the stock moved +13.8%, year the stock moved +7.3%. Its closing range over 52 weeks is ₹362.05 – ₹665.15, with the latest close 15.7% below the high.
Closing prices up to 2026-10-13.
About Coral Laboratories
Incorporated in 1994, Coral Laboratories Ltd is in the business of pharmaceutical formulations[1]
Business Overview:[1] CLL is an ISO 9001:2008 certified manufacturer and exporter of pharmaceutical formulations like tablets, capsules, liquid, and topical preparations. It focuses on generics, troubleshooting existing products, and patent noninfringing products for emerging markets.
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Coral Laboratories reported sales of ₹29.62 crore (+57.4%) and net profit of ₹5.39 crore (+110.5%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 29.62 | 5.49 | 18.53 | 5.39 | 15.09 |
| Mar 2026 | 26.48 | 6.20 | 23.41 | 5.22 | 14.61 |
| Dec 2025 | 21.56 | 1.89 | 8.77 | 2.78 | 7.78 |
| Sep 2025 | 19.03 | 4.94 | 25.96 | 5.82 | 16.29 |
| Jun 2025 | 18.82 | 2.18 | 11.58 | 2.56 | 7.17 |
| Mar 2025 | 28.13 | 2.69 | 9.56 | 2.83 | 7.92 |
| Dec 2024 | 22.99 | 6.32 | 27.49 | 6.14 | 17.19 |
| Sep 2024 | 32.23 | 6.51 | 20.20 | 6.38 | 17.86 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +39.2% | +27.2% | -2.6% | -40.6% | -41.0% | -6.2% | -5.9% | +57.4% |
| Operating profit growth | +5.9% | +201.0% | -57.0% | -79.7% | -24.1% | -70.1% | +130.5% | +151.8% |
| Net profit growth | +6.3% | +184.3% | -51.1% | -70.9% | -8.8% | -54.7% | +84.5% | +110.5% |
| EPS growth | +6.4% | +184.1% | -51.1% | -70.9% | -8.8% | -54.7% | +84.5% | +110.5% |
| OPM % | 20.2% | 27.5% | 9.6% | 11.6% | 26.0% | 8.8% | 23.4% | 18.5% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Coral Laboratories reported sales of ₹86.00 crore (-25.2%) and net profit of ₹16.00 crore (-33.3%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 86.00 | 15.00 | 18.00 | 16.00 | 45.85 |
| Mar 2025 | 115.00 | 26.00 | 23.00 | 24.00 | 67.63 |
| Mar 2024 | 84.00 | 16.00 | 19.00 | 16.00 | 44.20 |
| Mar 2023 | 78.00 | 4.00 | 5.00 | 6.00 | 18.05 |
| Mar 2022 | 76.00 | 8.00 | 11.00 | 9.00 | 25.33 |
| Mar 2021 | 97.00 | 16.00 | 16.00 | 14.00 | 37.93 |
| Mar 2020 | 71.00 | 5.00 | 8.00 | 7.00 | 19.96 |
| Mar 2019 | 91.00 | 12.00 | 14.00 | 10.00 | 28.61 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -1.1% | -22.0% | +36.6% | -21.6% | +2.6% | +7.7% | +36.9% | -25.2% |
| Operating profit growth | -20.0% | -58.3% | +220.0% | -50.0% | -50.0% | +300.0% | +62.5% | -42.3% |
| Net profit growth | -16.7% | -30.0% | +100.0% | -35.7% | -33.3% | +166.7% | +50.0% | -33.3% |
| EPS growth | -17.9% | -30.2% | +90.0% | -33.2% | -28.7% | +144.9% | +53.0% | -32.2% |
| OPM % | 14.0% | 8.0% | 16.0% | 11.0% | 5.0% | 19.0% | 23.0% | 18.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Coral Laboratories.
Get Free AI Stock Analysis FREE →Latest News
No recent news available for Coral Laboratories.
Frequently Asked Questions
What is Coral Laboratories's current stock price?
Coral Laboratories shares were last quoted at ₹560.90 (-2.0% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Coral Laboratories?
Coral Laboratories has a price-to-earnings (P/E) ratio of 10.80 and a price-to-book (P/B) ratio of 0.97. The industry P/E is 53.45.
What is the 52-week high and low of Coral Laboratories?
The 52-week high of Coral Laboratories is ₹679.00 and the 52-week low is ₹360.00.
What is the market cap of Coral Laboratories?
The market capitalisation of Coral Laboratories is about ₹207.48 crore.
How did Coral Laboratories perform in its latest quarterly results?
In the latest quarter (Jun 2026), Coral Laboratories reported sales of ₹29.62 crore (+57.4%) and net profit of ₹5.39 crore (+110.5%), compared with the same quarter last year.
Is Coral Laboratories a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Coral Laboratories has a 3-year ROE of 10.00%, 3-year profit growth of 36.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Coral Laboratories?
Promoters hold about 71.51% of Coral Laboratories.
Which sector does Coral Laboratories belong to?
Coral Laboratories belongs to the Pharmaceuticals & Drugs sector.